All subcategories » published RCT
KB001-A, a novel anti-inflammatory, found to be safe and well-tolerated in cystic fibrosis patients infected with Pseudomonas aeruginosa.
primary studies published RCT
Details- 2018
- Jain R
Antibiotic exposure and interpersonal variance mask the effect of ivacaftor on respiratory microbiota composition.
primary studies published RCT
Details- 2018
- Peleg AY
Study design considerations for the Standardized Treatment of Pulmonary Exacerbations 2 (STOP2): A trial to compare intravenous antibiotic treatment durations in CF.
primary studies published RCT
Details- 2018
- Heltshe SL
Children and Adults Tai Chi Study (CF-CATS2): a randomised controlled feasibility study comparing internet-delivered with face-to-face Tai Chi lessons in cystic fibrosis.
primary studies published RCT
Details- 2018
- Carr SB
Influence of the Vibralung Acoustical Percussor on pulmonary function and sputum expectoration in individuals with cystic fibrosis.
primary studies published RCT
Details- 2018
- Wheatley CM
Preventative Inhalation of Hypertonic Saline in Infants with Cystic Fibrosis (PRESIS): A Randomized, Double-Blind, Controlled Study.
primary studies published RCT
Details- 2018
- Stahl M
Effectiveness of a Home-Based Active Video Game Programme in Young Cystic Fibrosis Patients.
primary studies published RCT
Details- 2018
- Del Corral T
The role of small intestinal bacterial overgrowth in cystic fibrosis: a randomized case-controlled clinical trial with rifaximin.
primary studies published RCT
Details- 2018
- Furnari M
VX-445-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles.
primary studies published RCT
Details- 2018
- Keating D
Probiotics in cystic fibrosis patients: a double blind crossover placebo controlled study: pilot study from the ESPGHAN Working Group on Pancreas/CF
primary studies published RCT
Details- 2018
- Van Biervliet S